Serum lipids, apolipoproteins and total antioxidant activity levels of obese, diabetic and hypertensive subjects in an industrial set up in Baroda, Gujarat, India

International Journal of Diabetes in Developing Countries

Volumn 22, Issue 3, 2002, Pages 91-99

  Desai, S A ^a   Mani, U V ^a   Iyer, U M ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

Antioxidants; Apolipoproteins; Hypertension; Lipids; Type 2 diabetes

Indexed keywords

EID: 52449104557     PISSN: 09733930     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Gale CR, Ashurst HE, Powell HJ, Martyn CN. Antioxidant vitamin status and carotid atherosclerosis in the elderly. Am J Clin Nutr 2001;74:402-8.>
2. Gopalan C, Rama Sastri BV, Balasubramanian SC. Revised and updated by Narasinga Rao BS, Deosthale YG and Pant KC. Nutritive Value of Indian Foods. National Institute of Nutrition, Hyderabad, India, 1989.
3. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry. 1972;18:499-502.
4. Anjum Ahahid. Lipoproteins and Coronary Artery Disease. Jour Pakistan. Med. Association. 2000;50:35-40.
5. Anderson K, Wilson PWF, Odell PM, et al. An updated coronary risk profile. A statement for health professionals. Circulation. 1991;83:356.
6. Shestor DB, Deev AD, Kinov AN et al. Increased risk of coronary heart in men with low-density lipoprotein cholesterol in the Russian lipid research clinics, prevalence follow-up study. Circulation. 1993;88:846-53.
7. Burke AP, Farb A, Malcom GT et al. Coronary risk factors and plaque morphology in men with coronary diseases who died suddenly. N Engl J Med. 1997;336:1276-82.
8. Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein A1, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet. 2001;358:2026-33. [PUBMED] [FULLTEXT]
9. Field AE, Coakley EH, Must A, Spadano JL, Laird N, Dietz WH, Rimm E, Colidtz GA. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med. 2001;161[3]:1581-6.
10. Desai SA, Mani UV, Deshmukh SM, Iyer UM, Sen AK, Patel RP. Lifestyle risk factors for the development of chronic degenerative diseases in an industrial set up in Baroda. Int. J Diab Dev Countries. 2000;20:113-21.
11. Parikh P, Mani U, Iyer U. Role of Spirulina in the control of glycemia and lipidemia in Type 2 diabetes mellitus. Journal of Medical Foods. 2001;4:193-9. [PUBMED] [FULLTEXT]
12. George P, Ludvik B: Lipids and diabetes. J Clin Basic Cardiol. 2000;3:159-62.
13. Mani I, Mani UV. Serum triglyceride, cholesterol, lipoprotein cholesterol and urinary hydroxyproline levels in insulin dependent and non insulin dependent diabetes. J Clin Biochem Nutr. 1988;4:241-8.
14. Salonen JT, Salonen R, Seppanen K, Kantola M, Suntioinen S, Korpela H. Interactions of serum copper, selenium and low-density lipoprotein cholesterol in atherogenesis. Br Med J. 1991;302:756-60.
15. Esterbauer H, Gebicki J, Puhl H. Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med. 1992;13:341-90.
16. Steinberg D. Antioxidants in the prevention of human atherosclerosis. Summary of the proceedings of a National Heart, Lung, and Blood Institute Workshop: September 5-6, 1991, Bethesda, Maryland Circulation. 1992;85:2337-44. [PUBMED]
17. Luoma PV, Nahya S, Sakkila K, Hassi J. Antioxidants, diet and mortality from ischemic heart disease in rural communities in northern Finland. J Intern Med. 1995;237[1]:49-54.
18. Miller NJ and Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clinical Science 1993:84:407-12.